Company Filing History:
Years Active: 2020
Title: Yajuan Qin: Innovator in Nitric Oxide Synthase Inhibition
Introduction
Yajuan Qin is a prominent inventor based in Nanjing, China. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that inhibit nitric oxide synthases (NOSs). Her work has the potential to impact the treatment of various diseases associated with NOS activity.
Latest Patents
Yajuan Qin holds a patent for "Mammalian and bacterial nitric oxide synthase inhibitors." This patent discloses compounds that effectively inhibit the biological activity of nitric oxide synthases. Additionally, it includes pharmaceutical compositions comprising these compounds and methods for their use in treating subjects in need. The disclosed compounds may be utilized in methods for treating individuals who have or are at risk of developing diseases linked to NOS activity.
Career Highlights
Yajuan Qin is affiliated with Northwestern University, where she continues her research and development efforts. Her innovative work in the field of nitric oxide synthase inhibitors showcases her dedication to advancing medical science and improving patient outcomes.
Collaborations
Yajuan has collaborated with notable colleagues, including Richard B. Silverman and Heng-Yen Wang. These partnerships have further enriched her research and contributed to the advancement of her patented technologies.
Conclusion
Yajuan Qin's contributions to the field of nitric oxide synthase inhibition represent a significant advancement in pharmacological research. Her innovative compounds and methods hold promise for treating various diseases, highlighting her role as a key inventor in this important area of study.